Thinking Outside The Box
13-14 November 2026 | Premier Hotel O.R Tambo, Johannesburg
MASAC IMPACT 1995- TO DATE
MASAC Educational Symposium offers an unparalleled platform for advancing knowledge, collaboration, and innovation in the field of haemophilia and bleeding disorders. With a rich history dating back to 1995, this symposium has played a pivotal role in ensuring accurate diagnosis and optimal treatment for individuals with bleeding disorders, thanks to the involvement of multi-disciplinary teams in South Africa.
Read more articles, news from our SAHF MASAC team.
Read more articles, news from the world of haemophilia and other bleeding disorders.
The 79th World Health Assembly adopted a resolution on Global Action to Advance Health Equity for People with Haemophilia and Other Bleeding Disorders on 22 May 2026. The resolution recognises the need for strengthened global coordination, improved diagnosis, sustained policy action, and better access to appropriate care for people living with inherited bleeding disorders. For healthcare professionals, policymakers, and patient organisations, this development reinforces the importance of comprehensive care models, national data systems, clinical guidance, and equitable treatment access.
Bradley Rayner was elected as a Lay Member of the World Federation of Hemophilia Board of Directors during the WFH Annual Meeting of the General Assembly at the WFH 2026 World Congress. SAHF is proud to recognise Bradley’s achievement and his sustained contribution to bleeding disorders care, advocacy, leadership development, and capacity-building across South Africa and the wider global community. His experience as a person with haemophilia A, former SAHF National Chairperson, WFH volunteer, trainer, mentor, and international advocate will continue to add important value to the global bleeding disorders movement.
Cédric Hermans, MD, PhD, newly elected WFH Vice President, Medical, has called for greater mobilisation of the global medical and scientific community in service of people with inherited bleeding disorders. His statement places strong emphasis on connecting research, clinical practice, healthcare systems, and therapeutic innovation to measurable improvements in diagnosis, treatment access, and patient outcomes. SAHF MASAC welcomes this focus, particularly its alignment with comprehensive care, evidence-based guidance, registry development, multidisciplinary collaboration, and the global Treatment for All vision.
The 2024 International Hemophilia Training Centre (IHTC) Fellowships Call for Applications is now open! The IHTC Fellowship Program provides training in all aspects of bleeding disorders management for healthcare professionals in developing countries. Since the Program was launched in 1972, nearly 800 healthcare professionals from more than 100 countries have received training..
For 60 years, hemophilia treatment has advanced dramatically. Unfortunately, the World Health Organization’s (WHO) 2023 Essential Medicines List (EML) does not reflect current international clinical guidelines for hemophilia. The World Federation of Hemophilia (WFH) is gravely concerned about this development, and the leading experts involved in our organization have published an article in The Lancet Haematology outlining our standpoint.
Drs Pasi and Mahlangu discuss the prospects for gene therapy for hemophilia..
Upcoming events
7 - 8 November 2025 | OR Tambo Protea Hotel by Marriot, Johannesburg
6 November 2025 | Protea Hotel OR Tambo, Johannesburg
6 November 2025 | Protea Hotel OR Tambo, Johannesburg